168 related articles for article (PubMed ID: 36377010)
1. Induction Chemotherapy Response in Childhood Acute Lymphoblastic Leukaemia and its Correlation with Cytogenetic and Molecular Features.
Rana NA; Mahmood A; Robert HM; Zahir S; Ali I; Riaz S
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1430-1434. PubMed ID: 36377010
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic Profile Of Acute Lymphoblastic Leukaemia Patients And Its Association With Induction Remission Status.
Niaz H; Malik HS; Mahmood R; Mehmood A; Nisar U; Jalil S
J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S909-S912. PubMed ID: 36550642
[TBL] [Abstract][Full Text] [Related]
3. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
[TBL] [Abstract][Full Text] [Related]
4. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
[TBL] [Abstract][Full Text] [Related]
5. Clinico-Haematologic Parameters And Assessment Of Post-Induction Status In Acute Lymphoblastic Leukaemia.
Niaz H; Malik HS; Mahmood R; Mehmood A; Zaidi SA; Nisar U
J Ayub Med Coll Abbottabad; 2022; 34(3):458-462. PubMed ID: 36377156
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
Chessels JM; Swansbury GJ; Reeves B; Bailey CC; Richards SM
Br J Haematol; 1997 Oct; 99(1):93-100. PubMed ID: 9359508
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed between 2001 and 2014.
Yin MM; Wu RC; Gao J; Hu SY; Liu XM; Zhu XF; Shen SH; Tang JY; Chen J; Hu Q
Curr Med Sci; 2022 Feb; 42(1):201-209. PubMed ID: 34874488
[TBL] [Abstract][Full Text] [Related]
9. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong.
Tsang KS; Li CK; Chik KW; Shing MM; Tsoi WC; Ng MH; Lau TT; Leung Y; Yuen PM
Am J Hematol; 2001 Oct; 68(2):91-8. PubMed ID: 11559948
[TBL] [Abstract][Full Text] [Related]
10. Importance of FISH combined with Morphology, Immunophenotype and Cytogenetic Analysis of Childhood/ Adult Acute Lymphoblastic Leukemia in Omani Patients.
Goud TM; Al Salmani KK; Al Harasi SM; Al Musalhi M; Wasifuddin SM; Rajab A
Asian Pac J Cancer Prev; 2015; 16(16):7343-50. PubMed ID: 26514535
[TBL] [Abstract][Full Text] [Related]
11. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
12. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
[TBL] [Abstract][Full Text] [Related]
13. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R
Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991
[TBL] [Abstract][Full Text] [Related]
14. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
[TBL] [Abstract][Full Text] [Related]
16. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
Moorman AV; Ensor HM; Richards SM; Chilton L; Schwab C; Kinsey SE; Vora A; Mitchell CD; Harrison CJ
Lancet Oncol; 2010 May; 11(5):429-38. PubMed ID: 20409752
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: experience from India.
Amare P; Gladstone B; Varghese C; Pai S; Advani S
Cancer Genet Cytogenet; 1999 Apr; 110(1):44-53. PubMed ID: 10198622
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetics in childhood acute lymphoblastic leukemia: a hospital-based observational study.
Pandita A; Harish R; Digra SK; Raina A; Sharma AA; Koul A
Clin Med Insights Oncol; 2015; 9():39-42. PubMed ID: 25861237
[TBL] [Abstract][Full Text] [Related]
19. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study.
Harrison CJ; Moorman AV; Barber KE; Broadfield ZJ; Cheung KL; Harris RL; Jalali GR; Robinson HM; Strefford JC; Stewart A; Wright S; Griffiths M; Ross FM; Harewood L; Martineau M
Br J Haematol; 2005 May; 129(4):520-30. PubMed ID: 15877734
[TBL] [Abstract][Full Text] [Related]
20. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
